-
Genomic determination for Homologous Recombination Deficiency (HRD) by shallow Whole Genome Sequencing (sWGS)
Study
EGAS00001005926
-
RNA-seq on patient-derived, stage II, CRC cell lines
Study
EGAS00001005948
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals.
Study
EGAS00001005985
-
To determine the genomic profile of Triple Negative Breast Cancer patient-derived xenografts (PDX cohort)
Study
EGAS00001005995
-
Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas (COH_TNBC_RNAseq)
Study
EGAS00001006002
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Genomic and transcriptome analysis for intrahepatic cholangiocarcinoma
Study
EGAS00001006007
-
Application of high-throughput, high-depth, targeted single-nucleus DNA sequencing in pancreatic cancer
Study
EGAS00001006024